Icahn School of Medicine at Mount Sinai
Mount Sinai - Twitter Mount Sinai - YouTube Mount Sinai IPM Institute - Facebook

About Us

The Charles Bronfman Institute for Personalized Medicine (IPM) was created to drive innovation in the data-driven and gene-based individualization of healthcare.

The Institute’s groundbreaking work has led to the creation of the BioMe™ Biobank Program and the CLIPMERGE Technology to make genome-informed personalized medicine possible today.

Over 30,000 Mount Sinai patients have signed up for cutting edge genomic research through BioMe™ and their Mount Sinai doctors are already using their DNA for better and safer personalized treatment. Our world-class faculty is leading the way in discovering genetic underpinnings of common diseases and in advancing genome-informed medicine at the Mount Sinai Health System.

Meet the Director Who is IPM Community Support Current Funding Opportunities Contact Us